This announcement is a separate document:
昭衍新药2025年第一次临时股东大会、2025年第一次A股类别股东会议及2025年第一次H股类别股东会议会议资料
Information on the 2025 First Extraordinary General Meeting of Shareholders of Zhaoyan Pharmaceutical, the first Class A Shareholders\' Meeting in 2025, and the First Class H Shareholders\' Meeting in 2025
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.